Videos

Tagrisso Combination Improves Survival in EGFR-Mutant NSCLC

October 6th 2025, 8:00pm

In EGFR-mutated non-small cell lung cancer Tagrisso with pemetrexed and chemotherapy was associated with an improvement in survival.

What Is CAR-T Cell Therapy’s Role in Pediatric Solid Tumors?

October 6th 2025, 1:00pm

CAR-T cell therapy has cured some children with blood cancers and is being studied in solid tumors, where responses differ due to how these cancers grow.

Why Is Patient Advocacy Important During Breast Cancer Awareness Month?

October 3rd 2025, 8:00pm

Jennie Smythe, diagnosed with breast cancer at 41, now works with Susan G. Komen to amplify patient voices and drive progress in research and policy.

Reclaiming Intimacy for Women After Cancer

October 3rd 2025, 7:00pm

Kelly Dyckman works to help women reclaim their confidence in intimacy following a cancer journey, as she explained in an interview with CURE.

Remote Monitoring May Improve Recovery After Cancer Surgery

October 2nd 2025, 9:00pm

Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness

October 2nd 2025, 1:00pm

Alison Ankiewicz explains how pelvic physical therapy restores tissue, sexual function and emotional confidence for patients after cancer treatment.

Understanding the Evolving Role of a Pathologist in Lung Cancer Care

October 1st 2025, 1:00pm

Dr. Mary B. Beasley discusses evolving role of pathologists in lung cancer care, highlighting how emerging technologies may shape the future of the field.

Safe Food Practices at Home for Immunocompromised Patients With Cancer

September 30th 2025, 9:00pm

Heather Ann Yonker expands on strategies for maintaining food safety in the home, particularly for patients with compromised immune systems due to cancer.

Positive Experience With TAR-200 for Recurrent Bladder Cancer

September 30th 2025, 8:00pm

Frank Garred, 77, completed Inlexzo treatment for recurrent bladder cancer, describing it as manageable with minimal side effects compared with BCG.

Combination Therapies May Improve Survival in EGFR+ Lung Cancer

September 30th 2025, 1:00pm

Dr. Edgardo Santos explains that combining Tagrisso with chemotherapy or Leclaza plus Rybrevant may improve survival versus monotherapy alone.